Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate CancerN. Engl. J. Med 2022 Feb 17;[EPub Ahead of Print], MR Smith, M Hussain, F Saad, K Fizazi, CN Sternberg, ED Crawford, E Kopyltsov, CH Park, B Alekseev, Á Montesa-Pino, D Ye, F Parnis, F Cruz, TLJ Tammela, H Suzuki, T Utriainen, C Fu, M Uemura, MJ Méndez-Vidal, BL Maughan, H Joensuu, S Thiele, R Li, I Kuss, B Tombal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.